A RANKL–PKCβ–TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts

  1. Gerard Karsenty1,12
  1. 1Department of Genetics and Development, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA;
  2. 2Telethon Institute of Genetics and Medicine (TIGEM), Naples 80131, Italy;
  3. 3Medical Genetics, Department of Pediatrics, Federico II University, Naples 80131, Italy;
  4. 4Department of Molecular and Human Genetics, Baylor College of Medicine, Houston 77030, Texas, USA;
  5. 5Jan and Dan Duncan Neurological Research Institute, Texas Children Hospital, Houston 77030, Texas, USA;
  6. 6Department of Cell Biology,
  7. 7Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx 10461, New York, USA;
  8. 8Fukushima Medical University, Fukushima 960-1295, Japan;
  9. 9Soma Central Hospital, Fukushima 976-0013, Japan;
  10. 10Department of Pediatrics, University of Washington School of Medicine, Seattle 98101, Washington, USA
    • 11 Present address: Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada.

    Abstract

    Bone resorption by osteoclasts requires a large number of lysosomes that release proteases in the resorption lacuna. Whether lysosomal biogenesis is a consequence of the action of transcriptional regulators of osteoclast differentiation or is under the control of a different and specific transcriptional pathway remains unknown. We show here, through cell-based assays and cell-specific gene deletion experiments in mice, that the osteoclast differentiation factor RANKL promotes lysosomal biogenesis once osteoclasts are differentiated through the selective activation of TFEB, a member of the MITF/TFE family of transcription factors. This occurs following PKCβ phosphorylation of TFEB on three serine residues located in its last 15 amino acids. This post-translational modification stabilizes and increases the activity of this transcription factor. Supporting these biochemical observations, mice lacking in osteoclasts—either TFEB or PKCβ—show decreased lysosomal gene expression and increased bone mass. Altogether, these results uncover a RANKL-dependent signaling pathway taking place in differentiated osteoclasts and culminating in the activation of TFEB to enhance lysosomal biogenesis—a necessary step for proper bone resorption.

    Keywords

    Footnotes

    • Received January 11, 2013.
    • Accepted March 21, 2013.
    | Table of Contents

    Life Science Alliance